Pharm
Antiplatelet Management in Diabetes Mellitus
search
Antiplatelet Management in Diabetes Mellitus
, Aspirin Use in Diabetes
See Also
Antiplatelet Therapy for Vascular Disease
Background
Aspirin
has historically been considered in all diabetic patients or starting at age 45 years in men and age 55 years in women
However consider benefit of 7 years
Aspirin
(1 less CV event in 90) versus life threatening bleeding risk (1 in 110)
(2018) Presc Lett 25(11): 61
Indications
Low dose
Aspirin
81 mg daily (more specific as of 2012)
Framingham risk >10%, no vascular disease, and no
Bleeding Diathesis
Males over age 50 years or females over age 60 years and
One additional
Cardiovascular Risk Factor
Tobacco Abuse
Hypertension
Dyslipidemia
Albuminuria
Family History
of premature cardiovascular death
Indications
Clopidogrel
(
Plavix
) 75 mg daily
Known cardiovascular disease
Adverse Effects
See
Aspirin
Aspirin
does not increase risk of
Retina
l
Hemorrhage
Type your search phrase here